Grant Closeout Requirements
This section provides details regarding required documentation that must be submitted to Agency for Healthcare Research and Quality's (AHRQ) Grants Management within 120 days of the project end date of a grant or cooperative agreement to close out a grant in accordance with U.S. Department of Health and Human Services (HHS) regulations and 麻豆传媒 policy. A final Federal Financial Report is required for all projects. Unless a competitive renewal is funded, a Final Progress Report and Final Invention Statement and Certification must also be submitted.
Contents
Final Federal Financial Report
Final Invention Statement and Certification
Final Progress Report
Submission Requirements
Failure to Comply
Final Federal Financial Report (FFR)
The final Federal Financial Report submitted must agree with the final expenditures reported to the Payment Management System. Use Standard Form 425, form and instructions available online at: . AHRQ grantees are to report cumulative expenditure data for this grant award on the FFR; AHRQ grantees may not report expenditures for multiple awards on a single FFR.
All Federal Financial Reports (FFRs) (annual and final) due on or after January 1, 2021, are to be submitted electronically via the Payment Management System (PMS).
Please note that FFRs are not required for Fellowship (F31, F32) grant awards.
Final Invention Statement and Certification
This statement shall include all inventions which were conceived or put into practice during the entire project period. Use Form HHS 568, which is available online at: ()
Final Progress Report
The Final Progress Report is needed to describe the results of the research funded by the Agency. It will be made available to the public, and, therefore, should not include any copyrighted, private, or proprietary information.
The Final Progress Report is subject to a 20-page limit (minimum of 4 pages). Reports exceeding 20 pages will not be accepted. The report format should follow the AHRQ Grant Final Report Template at: http://www.ahrq.gov/funding/grants/process/reptemp.html.
It is required that the final progress report include, within the 20-page limit, information regarding progress related to the inclusion of 麻豆传媒 priority populations including any research results relevant to one or more priority populations (Go to for AHRQ's Policy on the Inclusion of Priority Populations in Research). 麻豆传媒 program staff will evaluate inclusion of priority populations in the project, including the extent to which actual recruitment and retention of subjects was consistent with the recruitment plan proposed in the initial grant application. There is no pre-specified format for this report, though a narrative accompanied by a table showing anticipated vs. actual recruitment may be appropriate. Please clearly label this section of the progress report.
If the project includes a Minority Supplement, the Final Progress Report must include, within the 20-page limit, a distinctly identified Final Progress Report for the Minority Supplement project.
A list of publications and products generated by the grant and representing the outputs of the study should be included and follow the 麻豆传媒 Citation Style Format.
For further details on the requirements of the Final Progress Report, contact your project officer.
If you have copies of publications (not previously submitted) that resulted from the grant project, submit these under separate cover directly to the project officer of your grant; do not include them as part of the Final Progress Report.
Submission Requirements
Submit the Final Federal Financial Report (SF 425) electronically via the Payment Management System (PMS).
Submit the Final Progress Report as an electronic file attachment via Email to: grantfpr@ahrq.hhs.gov. The only acceptable format is Word庐. PDF files are not acceptable for the Final Progress Report.
Submit the Final Invention Statement (HHS 568) as a PDF file to: grantfpr@ahrq.hhs.gov.
Failure to Comply
Failure to submit the required reports in a timely manner may result in the imposition of a special award provision or the withholding of funding of other eligible projects or activities involving the grantee organization or the principal investigator.
